
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Achilles Therapeutics mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. The therapies will target truncal (also known as clonal) tumour neo-antigens, unique flags to the immune system present on the surface of every cancer cell. These truncal neo-antigens are created early in the cancers evolution and present on all cancer cells in an individual patients tumour but not on healthy cells, so could allow scientists to target and destroy tumours without harming healthy tissues. Achilles Therapeutics brings together four scientific Founders with world leading expertise in the understanding of cancer evolution, bioinformatics...
Neo-antigens,immunotherapies,bioinformatics ,biotech,translational science,and oncology
Achilles therapeutics plc operates in the Biotechnology research industry.
Achilles therapeutics plc's revenue is 11m - 100m
Achilles therapeutics plc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.